Stock ODX CAMBRIDGE NUTRITIONAL SCIENCES PLC
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Cambridge Nutritional Sciences plc

Equities

ODX

GB00B1VCP282

Delayed London S.E.
Other stock markets
 11:45:48 20/06/2024 BST 		5-day change 1st Jan Change
3.55 GBX -1.39% Intraday chart for Cambridge Nutritional Sciences plc -10.13% +47.92%
05-24 Cambridge Nutritional Sciences appoints James Copper as COO AN
05-24 Cambridge Nutritional Sciences Names COO MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024
CI
Cambridge Nutrition loss narrows as revenue surges; outlook optimistic
AN
Earnings Flash (CNSL.L) CAMBRIDGE NUTRITIONAL SCIENCES Reports H1 Revenue GBP4.9M
MT
Earnings Flash (CNSL.L) CAMBRIDGE NUTRITIONAL SCIENCES Reports Fiscal H1 Loss GBX-0.30
MT
Cambridge Nutritional Sciences plc Reports Earnings Results for the Half Year Ended September 30, 2023
CI
Cambridge Nutritional Sciences plc Provides Revenue Guidance for the Fiscal Year 2024
CI
Solid State sees strong orders in security & defence
AN
Omega Diagnostics Group plc Appoints Carolyn Rand as an Independent Non-Executive Director
CI
Omega Diagnostics says revenue and loss hurt by operational issues
AN
Earnings Flash (ODX.L) OMEGA DIAGNOSTICS GROUP Reports FY23 Revenue GBP7.5M
MT
Earnings Flash (ODX.L) OMEGA DIAGNOSTICS GROUP Reports FY23 Loss GBX-1.70
MT
Omega Diagnostics Group PLC Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Omega Diagnostics shares down as annual loss set to widen
AN
AIM WINNERS & LOSERS: DeepVerge plunges on accounting bungle
AN
Possible offers for Network International, John Wood
AN
TRADING UPDATES: Triad hails recovery; Alpha Group profit tops outlook
AN
Omega Diagnostics Group Books Maiden Order For FoodPrint System From US Laboratory
MT
Omega Receives Maiden Purchase Order for Its Foodprint System from CLIA Certified Laboratory in the United States
CI
IN BRIEF: Omega Diagnostics receives CD4 deferred consideration
AN
Omega Diagnostics Receives $5 Million Deferred Consideration From CD4 Sale
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ODX Stock
  4. News Cambridge Nutritional Sciences plc
  5. Highlights